Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars
source: pixabay.com

Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars

According to a story from ankylosingspondylitisnews.com, a significant proportion of patients stopped taking a biosimilar for infliximab within six months of transitioning to the new medication. This suggests that the…

Continue Reading Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars
New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising
Source: Pixabay.com

New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising

According to a story from The Irish Times, a new campaign is encouraging people with the rare lung condition idiopathic pulmonary fibrosis to keep exercising. The campaign is centered around…

Continue Reading New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising
A Physician Sees the Patient Perspective When Getting Treated For Primary Periodic Paralysis
source: pixabay.com

A Physician Sees the Patient Perspective When Getting Treated For Primary Periodic Paralysis

According to a story from Neurology Advisor, a retired physician experienced the challenges of being a rare disease patient first hand after being diagnosed with primary periodic paralysis thanks to…

Continue Reading A Physician Sees the Patient Perspective When Getting Treated For Primary Periodic Paralysis
Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
source: pixabay.com

Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA

According to a recent story from pm360online.com, the pharmaceutical company Shire announced that the marketing application for its drug product lanadelumab has gained approval from the European Medicines Agency (EMA).…

Continue Reading Treatment for Hereditary Angiodema Gets Marketing Approval From the EMA
An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?
source: pixabay.com

An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?

According to a recent story from CityNews Toronto, Alara Ozkose's Dravet syndrome was preventing her from being able to live a life that was even close to normal. She was…

Continue Reading An Experimental Drug Was Helping A Girl With Dravet Syndrome. Will She Lose Access After the Trial?
Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation
source: pixabay.com

Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation

According to a story from 4-traders.com, the pharmaceutical company SteroTherapeutics recently announced that its drug candidate ST-002 was awarded Orphan Drug Designation by the U.S. Food and Drug Administration (FDA).…

Continue Reading Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation
NBA Hall of Famer Diagnosed with Amyloidosis, Decides to Help Fellow Retirees
Source: Pixabay

NBA Hall of Famer Diagnosed with Amyloidosis, Decides to Help Fellow Retirees

A story published on ESPN.com, and written by Jackie MacMullan, details NBA Hall of Fame inductee Nate "Tiny" Archibald's diagnosis of the rare disease amyloidosis. Amyloidosis occurs when a substance called amyloid builds…

Continue Reading NBA Hall of Famer Diagnosed with Amyloidosis, Decides to Help Fellow Retirees
A New Rare Disease Podcast Amplifies Patient Voices
https://pixabay.com/en/audio-technology-mixer-volume-knob-1839162/

A New Rare Disease Podcast Amplifies Patient Voices

Rare in Common, a new monthly podcast which features stories about patients with rare diseases, made its debut on Rare Disease Day, February 28th. The podcast's goal is to raise awareness and…

Continue Reading A New Rare Disease Podcast Amplifies Patient Voices